Pulse Biosciences PLSE 深 滬
已收盤 11-06 16:00:00 美东时间
53.29
+0.220
+0.41%
華盛通- 最 高56.87
- 今 開56.87
- 成交量 42.85万股
- 最 低 50.31
- 昨 收 53.07
- 總市值 38.01亿
- 52周最高 58.90
- 市盈率 靜 --
- 換手率 0.60%
- 52周最低 12.56
- 委 比 75.65%
- 總股本 7132.26万
- 歷史最高 58.90
- 量 比 1.00
- 振 幅 12.36%
- 歷史最低 1.18
- 每 手 1
- 風險率 13.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulse Biosciences 2026财年第3季度营收39.5万美元，同比增长359.30%
最新财报显示，Pulse Biosciences 2026财年第3季度实现： 营业收入：39.5万美元 同比：增长359.30% 每股收益：-0.32美元 同比...
11-07 08:00
Pulse Biosciences Presents Six-Month Interim Results From PRECISE-BTN Thyroid Nodule Study, At 95th ATA Annual Meeting
86% of patients evaluated achieved at least 50% nodule volume reduction at six months after a single nonthermal nsPFA treatment, with significant improvements in symptoms and quality of life and no serious adverse events Pulse Biosciences, Inc. (NASDAQ:PLSE), the company leveraging its ever evolvin...
11-06 20:05
Pulse Biosciences收涨1.26%，成交额1322.92万美元
11月3日，Pulse Biosciences（PLSE）收涨1.26%，报52.9美元，成交额1322.92万美元，市值37.73亿美元。 行情数据 • 开盘...
11-03 06:11
Pulse Biosciences收跌0.68%，成交额1493.1万美元
10月27日，Pulse Biosciences（PLSE）收跌0.68%，报52.66美元，成交额1493.1万美元，市值37.56亿美元。 行情数据 • 开...
10-27 05:12
Pulse Biosciences收跌2.54%，成交额1448.2万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:17
Pulse Biosciences Partners With Clayman Thyroid Center At Hospital For Endocrine Surgery In Tampa, Florida
Collaboration adds the nPulse™ Vybrance™ System to patient care at the Hospital for Endocrine Surgery and supports generation of additional clinical data Pulse Biosciences, Inc. (NASDAQ:PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA ...
10-14 19:06
Pulse Biosciences Completes Enrollment in NANOPULSE-AF Trial
Pulse Biosciences ( ($PLSE) ) has issued an announcement. On October 7, 2026, P...
10-07 21:28
美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $58
Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $43 to $58.
10-07 02:18
